Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Published by: Harvard Business Publishing
Originally published in: 2002
Version: 8 February 2002
Length: 22 pages
Data source: Field research

Abstract

Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.; Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research.

About

Abstract

Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.; Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research.

Related